| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Sodium bicarbonate 4.2% solution for injection 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sodium perchlorate 200mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Insulin degludec 100units/ml solution for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Insulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cisatracurium besilate 20mg/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cisatracurium besilate 10mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cisatracurium besilate 5mg/2.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Chloroprocaine 50mg/5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cefuroxime 1mg/0.1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Midazolam 5mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Dexamethasone 6.6mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Cefuroxime 300micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ephedrine 30mg/10ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Filgrastim 48million units/0.8ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sugammadex 200mg/2ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sugammadex 500mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methoxy polyethylene glycol-epoetin beta 30micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methoxy polyethylene glycol-epoetin beta 120micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methoxy polyethylene glycol-epoetin beta 360micrograms/0.6ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 25mg/3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Icatibant 30mg/3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ustekinumab 45mg/0.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Normal immunoglobulin human 480mg/3ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Normal immunoglobulin human 3.2g/20ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Apomorphine 2mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Magnesium sulphate 20% solution for injection 20ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Droperidol 2.5mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 7.5mg/0.15ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 10mg/0.2ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 15mg/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 25mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 20mg/0.4ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Oxycodone 50mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Insulin human 500units/ml solution for injection 20ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ethanol solution for injection 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ribavirin 1.2g/12ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hydromorphone 50mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Liraglutide 18mg/3ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Etanercept 50mg/1ml solution for injection 1ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Papaveretum 30mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Plerixafor 24mg/1.2ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Promethazine 50mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline 500micrograms/0.3ml (1 in 600) solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Prilocaine 100mg/5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Sildenafil 40mg/50ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin zeta 20,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin zeta 30,000units/0.75ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 1,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 3,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 4,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 5,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 10,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 2,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 30,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Epoetin theta 20,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Histamine dihydrochloride 500micrograms/0.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Denosumab 60mg/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gadoteridol 0.5mmol/ml solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gadoteridol 0.5mmol/ml solution for injection 15ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gadoteridol 0.5mmol/ml solution for injection 20ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Corifollitropin alfa 100micrograms/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Filgrastim 12million units/0.2ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Corifollitropin alfa 150micrograms/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Interferon alfa-2b 10million units/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Hepatitis B immunoglobulin human 500unit solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Paraldehyde 5g/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Normal immunoglobulin human 3.3g/20ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Normal immunoglobulin human 1.65g/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ferric derisomaltose 100mg/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ferric derisomaltose 500mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Ferric derisomaltose 1g/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Terlipressin 1mg/8.5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Disodium folinate 200mg/4ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Disodium folinate 50mg/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Golimumab 50mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Insulin human 100units/ml solution for injection 3.15ml cartridges |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Mecobalamin 500micrograms/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atracurium besilate 250mg/25ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Methotrexate 30mg/0.6ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adrenaline 150micrograms/0.15ml (1 in 1,000) solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Adalimumab 40mg/0.4ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Potassium acetate 49% (potassium 50mmol/10ml) solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Potassium acetate 19.6% (potassium 20mmol/10ml) solution for injection 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Potassium acetate 19.6% (potassium 20mmol/10ml) solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Potassium acetate 19.6% (potassium 200mmol/100ml) solution for injection 100ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Glucose 2.5g/10ml / Phenol 250mg/10ml / Glycerol 2.5ml/10ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Moxifloxacin 0.5mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Zinc sulfate 200micromol/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Calcium gluconate 10% solution for injection 50ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gadodiamide 0.5mmol/ml solution for injection 10ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Atropine 40micrograms/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
| Gadodiamide 0.5mmol/ml solution for injection 15ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|